Literature DB >> 19020152

Propofol pretreatment attenuates aquaporin-4 over-expression and alleviates cerebral edema after transient focal brain ischemia reperfusion in rats.

Yue-Ying Zheng1, Yun-Ping Lan, Hui-Fang Tang, Sheng-Mei Zhu.   

Abstract

BACKGROUND: Cerebral edema is a major threat for stroke victims. Most studies have focused on the neuroprotective activities of propofol, addressing infarct volume rather than cerebral edema. Aquaporin-4 (AQP4) plays an important role in maintaining brain water homeostasis under various neurological insults. We explored the effect of propofol pretreatment on cerebral edema in a rat model of brain ischemia reperfusion and assessed the involvement of AQP4.
METHODS: To induce brain ischemia reperfusion, we introduced a silicone-coated monofilament nylon suture into the origin of the middle cerebral artery, withdrawing it after 90 min. Treatment groups (n = 32), received propofol (0.1 mL x kg(-1) x min(-1)) infusion for 30 min before occlusion; the vehicle group (n = 32) and the sham-operated group (n = 28), which received the intralipid vehicle at the same time and rate. To assess cerebral infarct volume, we used 2, 3, 5-triphenyl-tetrazolium chloride staining; wet-dry weight ratio was the basis for cerebral edema estimation, and we used immunohistochemistry and Western blot to detect AQP4 expression.
RESULTS: The wet-dry weight ratio decreased from 86.89% +/- 0.71% in the vehicle group (n = 6) to 72.42% +/- 0.74% in the propofol group (n = 6), corresponding to an average decrease of 16%. In parallel and based on immunohistochemical semi-quantification, the propofol group exhibited remarkable attenuation of AQP4 over-expression in the ischemic border zone compared with the vehicle group: 1.28 +/- 0.03 vs 1.40 +/- 0.05, n = 7, respectively; P < 0.05. Values derived from Western blot quantification were similarly decreased in the propofol group compared to the vehicle group: 20.85% +/- 4.18% vs 31.67% +/- 3.23%, n = 4, respectively; P < 0.05. However, infarct volume and neurologic deficit in postischemic rats in the propofol group were not statistically different from values in the vehicle group.
CONCLUSIONS: We conclude that prestroke treatment with propofol reduces postischemic cerebral edema in rats, possibly through inhibiting AQP4 over-expression in the boundary zone of ischemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19020152     DOI: 10.1213/ane.0b013e318187c313

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  24 in total

1.  Effect of propofol post-treatment on blood-brain barrier integrity and cerebral edema after transient cerebral ischemia in rats.

Authors:  Jae Hoon Lee; Hui Song Cui; Seo Kyung Shin; Jeong Min Kim; So Yeon Kim; Jong Eun Lee; Bon-Nyeo Koo
Journal:  Neurochem Res       Date:  2013-08-29       Impact factor: 3.996

2.  Propofol induces apoptosis and increases gemcitabine sensitivity in pancreatic cancer cells in vitro by inhibition of nuclear factor-κB activity.

Authors:  Qi-Hang Du; Yan-Bing Xu; Meng-Yuan Zhang; Peng Yun; Chang-Yao He
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

3.  Ischemic Postconditioning Alleviates Brain Edema After Focal Cerebral Ischemia Reperfusion in Rats Through Down-Regulation of Aquaporin-4.

Authors:  Dong Han; Miao Sun; Ping-Ping He; Lu-Lu Wen; Hong Zhang; Juan Feng
Journal:  J Mol Neurosci       Date:  2015-02-08       Impact factor: 3.444

Review 4.  Aquaporins in cerebrovascular disease: a target for treatment of brain edema?

Authors:  J Badaut; S Ashwal; A Obenaus
Journal:  Cerebrovasc Dis       Date:  2011-04-12       Impact factor: 2.762

Review 5.  Regulation and Function of AQP4 in the Central Nervous System.

Authors:  Mette Assentoft; Brian Roland Larsen; Nanna MacAulay
Journal:  Neurochem Res       Date:  2015-01-29       Impact factor: 3.996

Review 6.  Neuroinflammatory pathways in binge alcohol-induced neuronal degeneration: oxidative stress cascade involving aquaporin, brain edema, and phospholipase A2 activation.

Authors:  Michael A Collins; Edward J Neafsey
Journal:  Neurotox Res       Date:  2011-09-17       Impact factor: 3.911

7.  Propofol Attenuates Inflammatory Response in LPS-Activated Microglia by Regulating the miR-155/SOCS1 Pathway.

Authors:  Xinxun Zheng; Hongbing Huang; Jianjun Liu; Minghua Li; Min Liu; Tao Luo
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

8.  Probenecid protects against transient focal cerebral ischemic injury by inhibiting HMGB1 release and attenuating AQP4 expression in mice.

Authors:  Xiao-Xing Xiong; Li-Juan Gu; Jian Shen; Xian-Hui Kang; Yue-Ying Zheng; Si-Biao Yue; Sheng-Mei Zhu
Journal:  Neurochem Res       Date:  2013-12-07       Impact factor: 3.996

9.  Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury.

Authors:  Anatol Manaenko; Nancy Fathali; Nikan H Khatibi; Tim Lekic; Yu Hasegawa; Robert Martin; Jiping Tang; John H Zhang
Journal:  Neurochem Int       Date:  2011-01-20       Impact factor: 3.921

10.  3,4-oxo-isopropylidene-shikimic acid inhibits cerebral ischemia-induced oxidative stress and neuronal apoptosis in rats.

Authors:  Ling-Ling Tang; Jing-Ya Ye; Sheng-Nan Jiang; Jie-Sheng Zheng
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.